Ryan Yakabosky
About Ryan Yakabosky
Ryan Yakabosky is a Cell Therapy Account Manager at Kite Pharma, with over a decade of experience in the pharmaceutical industry, including roles at Gilead Sciences and Sanofi. He holds a BS in Environmental Science from Wesley College, with minors in Biology and Chemistry.
Current Role at Kite Pharma
Ryan Yakabosky has been serving as a Cell Therapy Account Manager at Kite Pharma since 2019. In this role, he is responsible for managing accounts related to cell therapy products and ensuring effective communication between the company and healthcare providers. His position focuses on expanding the reach of Kite Pharma's innovative therapies in the Greater Philadelphia Area.
Professional Experience at Gilead Sciences
Since 2014, Ryan Yakabosky has worked at Gilead Sciences as a Senior Therapeutic Specialist and Regional Trainer. Over the course of ten years, he has contributed to the company's mission by providing training and support to sales teams while also engaging with healthcare professionals in the Greater Philadelphia Area.
Previous Experience in Sales and Consulting
Prior to his current roles, Ryan Yakabosky held various positions in the healthcare and consulting sectors. He worked as a Senior Specialty Sales Professional at Sanofi from 2004 to 2012, focusing on the New Jersey and Philadelphia markets. He also served as a District Sales Manager at Aramark Uniform Services from 1997 to 1999 and as a Senior Consultant at KPMG for 11 months in 2001.
Educational Background in Environmental Science
Ryan Yakabosky studied at Wesley College, where he earned a Bachelor of Science degree in Environmental Science. His academic background includes minors in Biology and Chemistry, providing him with a strong foundation in the sciences that supports his work in the pharmaceutical industry.
Experience in Oncology at Johnson & Johnson
Ryan Yakabosky worked as a Senior Oncology Specialist at Johnson & Johnson from 2012 to 2014. In this role, he focused on oncology products and contributed to the company's efforts in the New Jersey market, enhancing his expertise in the field of cancer treatment.